HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peter Schafer Selected Research

Peter Schafer Research Topics

Disease

9Psoriasis (Pustulosis Palmaris et Plantaris)
11/2021 - 11/2005
7Neoplasms (Cancer)
11/2022 - 02/2003
7Multiple Myeloma
01/2018 - 01/2005
6Psoriatic Arthritis
11/2021 - 10/2010
5Heart Failure
02/2024 - 02/2021
4Inflammation (Inflammations)
12/2021 - 11/2009
3Arthritis (Polyarthritis)
11/2022 - 01/2010
2Fibrosis (Cirrhosis)
08/2023 - 01/2022
2Rheumatoid Arthritis
12/2022 - 01/2010
2Necrosis
12/2021 - 01/2010
2Myelodysplastic Syndromes (Myelodysplastic Syndrome)
10/2010 - 07/2008
2Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
11/2009 - 03/2006
2Weight Loss (Weight Reduction)
11/2009 - 03/2006
2Colonic Neoplasms (Colon Cancer)
01/2008 - 01/2005
1Myocardial Infarction
11/2023
1Pulmonary Fibrosis (Fibrosing Alveolitis)
08/2023
1Atherosclerosis
01/2022
1Aortic Valve Stenosis (Aortic Stenosis)
12/2021
1Oral Ulcer (Mouth Ulcer)
11/2021
1Heart Arrest (Cardiac Arrest)
02/2021
1Hematologic Diseases (Blood Diseases)
01/2021
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2021
1Ankylosing Spondylitis
01/2020
1Metabolic Diseases (Metabolic Disease)
05/2017
1Colorectal Neoplasms (Colorectal Cancer)
01/2011
1Venous Thromboembolism
01/2010
1Neutropenia
01/2010
1Experimental Arthritis
01/2010
1Disease Progression
11/2009
1Non-Hodgkin Lymphoma (Lymphosarcoma)
07/2008

Drug/Important Bio-Agent (IBA)

11Lenalidomide (CC 5013)FDA Link
05/2016 - 01/2005
9apremilastIBA
11/2021 - 01/2010
7Phosphodiesterase 4 InhibitorsIBA
11/2021 - 11/2005
6Biomarkers (Surrogate Marker)IBA
08/2023 - 12/2019
6Thalidomide (Thalomid)FDA Link
05/2016 - 02/2003
5Proteins (Proteins, Gene)FDA Link
11/2023 - 02/2003
4pomalidomideIBA
05/2016 - 07/2009
3CytokinesIBA
01/2021 - 11/2009
3iberdomideIBA
01/2021 - 01/2018
2Blood Proteins (Serum Proteins)IBA
02/2024 - 11/2023
2Mineralocorticoid Receptor AntagonistsIBA
11/2023 - 01/2022
2LigandsIBA
11/2022 - 01/2011
2InterleukinsIBA
12/2021 - 06/2012
2Interleukin-6 (Interleukin 6)IBA
12/2021 - 01/2020
2Type 4 Cyclic Nucleotide PhosphodiesterasesIBA
11/2021 - 01/2019
2Interleukin-17 (Interleukin 17)IBA
01/2020 - 12/2019
2Interleukin-12 (IL 12)IBA
01/2019 - 07/2008
2AntigensIBA
01/2011 - 07/2008
2AntibodiesIBA
01/2011 - 07/2008
2Immunomodulating AgentsIBA
01/2010 - 07/2009
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2010 - 11/2009
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
07/2008 - 01/2008
1Insulin (Novolin)FDA Link
11/2023
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
11/2023
1CreatinineIBA
11/2023
1JNK Mitogen-Activated Protein KinasesIBA
08/2023
1CC-90001IBA
08/2023
1Abatacept (Orencia)FDA Link
12/2022
1Anti-Citrullinated Protein AntibodiesIBA
12/2022
1Methotrexate (Mexate)FDA LinkGeneric
12/2022
1Antirheumatic Agents (DMARD)IBA
12/2022
1Collagen Type I (Type I Collagen)IBA
12/2022
1Interleukin-12 Subunit p40IBA
11/2022
1Phosphotransferases (Kinase)IBA
11/2022
1Peptides (Polypeptides)IBA
11/2022
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
11/2022
1ChemokinesIBA
11/2022
1CXC ChemokinesIBA
11/2022
1Chemokine CCL7IBA
11/2022
1Glycoproteins (Glycoprotein)IBA
01/2022
1ApelinIBA
01/2022
1Liver X ReceptorsIBA
01/2022
1Spironolactone (Aldactone)FDA LinkGeneric
01/2022
1EndostatinsIBA
12/2021
1pro-brain natriuretic peptide (1-76)IBA
12/2021
1Lipocalin-2IBA
12/2021
1Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
12/2021
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
12/2021
1Brain Natriuretic Peptide (Natrecor)FDA Link
12/2021
1Matrix Metalloproteinase 7 (Matrilysin)IBA
12/2021
1OsteoprotegerinIBA
12/2021
1Syndecan-1 (Syndecan 1)IBA
12/2021
1InflammasomesIBA
11/2021
1Apolipoproteins MIBA
02/2021
1Transcription Factors (Transcription Factor)IBA
01/2021
1Interleukin-23 (Interleukin 23)IBA
12/2019
1AdipokinesIBA
12/2019
1C-Reactive ProteinIBA
05/2017
1Interleukin-10 (Interleukin 10)IBA
06/2012
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
06/2012
1Tumor Biomarkers (Tumor Markers)IBA
01/2011
1Cetuximab (Erbitux)FDA Link
01/2011
1Trastuzumab (Herceptin)FDA Link
01/2011
1Collagen Type II (Type II Collagen)IBA
01/2010
1Fas Ligand Protein (Fas Ligand)IBA
11/2009
1Dexamethasone (Maxidex)FDA LinkGeneric
07/2009
1fludarabineIBA
07/2008
1IgG Receptors (Fc gamma RI)IBA
07/2008
1Immunoglobulin G (IgG)IBA
07/2008

Therapy/Procedure

3Therapeutics
01/2022 - 11/2005